DK609387D0 - HETEROARYLAMINOMETHANDIPHOSPHONIC ACIDS AND THEIR PREPARATION AND USE - Google Patents
HETEROARYLAMINOMETHANDIPHOSPHONIC ACIDS AND THEIR PREPARATION AND USEInfo
- Publication number
- DK609387D0 DK609387D0 DK609387A DK609387A DK609387D0 DK 609387 D0 DK609387 D0 DK 609387D0 DK 609387 A DK609387 A DK 609387A DK 609387 A DK609387 A DK 609387A DK 609387 D0 DK609387 D0 DK 609387D0
- Authority
- DK
- Denmark
- Prior art keywords
- phosphono
- denotes
- lower alkyl
- acids
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
- C07F9/65324—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/65392—Five-membered rings containing two nitrogen atoms
- C07F9/65397—Five-membered rings containing two nitrogen atoms having the two nitrogen atoms in positions 1 and 3
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Heteroarylaminomethanediphosphonic acids of the formula <IMAGE> in which R1 represents an optionally benzo- or cyclohexeno-fused 5-membered heteroaryl radical having 2 to 4 N atoms or 1 or 2 N atoms and 1 O or S atom as hetero atom(s) and which is unsubstituted or substituted by lower alkyl, phenyl which is unsubstituted or substituted by lower alkyl, lower alkoxy and/or halogen, lower alkoxy, hydroxyl, di-lower alkylamino, lower alkylthio and/or halogen and R2 denotes hydrogen or lower alkyl, and their salts have an action regulating the metabolism of calcium and can be used as pharmaceutical active compounds for the treatment of diseases which can be traced back to disorders thereof. They are prepared, for example, by converting the group(s) X into free phosphono in a compound of the formula <IMAGE> in which X1 denotes a functionally modified phosphono group X and X2 denotes phosphono or likewise a functionally modified phosphono group X.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH466586 | 1986-11-21 | ||
| CH466586 | 1986-11-21 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK609387D0 true DK609387D0 (en) | 1987-11-20 |
| DK609387A DK609387A (en) | 1988-05-22 |
| DK168869B1 DK168869B1 (en) | 1994-06-27 |
Family
ID=4280333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK609387A DK168869B1 (en) | 1986-11-21 | 1987-11-20 | Heter Garylaminomethane diphosphonic acids and their salts, processes for their preparation and pharmaceutical compositions containing them |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0274346B1 (en) |
| JP (1) | JPS63150290A (en) |
| KR (1) | KR880006217A (en) |
| AT (1) | ATE61371T1 (en) |
| AU (1) | AU605203B2 (en) |
| CA (1) | CA1324383C (en) |
| DD (1) | DD265900A5 (en) |
| DE (1) | DE3768463D1 (en) |
| DK (1) | DK168869B1 (en) |
| ES (1) | ES2038693T3 (en) |
| FI (1) | FI87653C (en) |
| GR (1) | GR3001611T3 (en) |
| HU (1) | HU201087B (en) |
| IE (1) | IE60148B1 (en) |
| IL (1) | IL84494A (en) |
| MY (1) | MY103191A (en) |
| NO (1) | NO170283C (en) |
| NZ (1) | NZ222608A (en) |
| PH (1) | PH23959A (en) |
| PT (1) | PT86166B (en) |
| ZA (1) | ZA878656B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR880011136A (en) * | 1987-03-11 | 1988-10-26 | 모리오까 시게오 | Azole-aminomethylene bisphosphonic acid derivatives |
| US5270365A (en) * | 1991-12-17 | 1993-12-14 | Merck & Co., Inc. | Prevention and treatment of periodontal disease with alendronate |
| TW237386B (en) * | 1992-04-15 | 1995-01-01 | Ciba Geigy | |
| EP0600834A1 (en) * | 1992-11-30 | 1994-06-08 | Ciba-Geigy Ag | Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing |
| US5880111A (en) * | 1995-06-07 | 1999-03-09 | Farcasiu; Dan | Therapeutic derivations of diphosphonates |
| PT854724E (en) * | 1995-09-29 | 2005-08-31 | Novartis Ag | METHOD OF TREATING NAVICULAR DISEASE IN HORSES |
| DE10226420A1 (en) * | 2002-06-13 | 2004-01-15 | Eucro European Contract Research Gmbh & Co Kg | Procedure for the treatment of atherosclerosis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54135724A (en) * | 1978-04-11 | 1979-10-22 | Nissan Chem Ind Ltd | Preparation of amino-methylenedisulfonic acid derivative |
| IL77243A (en) * | 1984-12-21 | 1996-11-14 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds |
-
1987
- 1987-11-16 AT AT87810665T patent/ATE61371T1/en not_active IP Right Cessation
- 1987-11-16 EP EP87810665A patent/EP0274346B1/en not_active Expired - Lifetime
- 1987-11-16 DE DE8787810665T patent/DE3768463D1/en not_active Expired - Lifetime
- 1987-11-16 ES ES198787810665T patent/ES2038693T3/en not_active Expired - Lifetime
- 1987-11-16 IL IL84494A patent/IL84494A/en not_active IP Right Cessation
- 1987-11-18 CA CA000552085A patent/CA1324383C/en not_active Expired - Fee Related
- 1987-11-18 PH PH36078A patent/PH23959A/en unknown
- 1987-11-18 FI FI875095A patent/FI87653C/en not_active IP Right Cessation
- 1987-11-19 DD DD87309213A patent/DD265900A5/en not_active IP Right Cessation
- 1987-11-19 PT PT86166A patent/PT86166B/en not_active IP Right Cessation
- 1987-11-19 ZA ZA878656A patent/ZA878656B/en unknown
- 1987-11-19 NZ NZ222608A patent/NZ222608A/en unknown
- 1987-11-20 IE IE314787A patent/IE60148B1/en not_active IP Right Cessation
- 1987-11-20 HU HU875159A patent/HU201087B/en not_active IP Right Cessation
- 1987-11-20 NO NO874855A patent/NO170283C/en unknown
- 1987-11-20 JP JP62292196A patent/JPS63150290A/en active Pending
- 1987-11-20 AU AU81452/87A patent/AU605203B2/en not_active Ceased
- 1987-11-20 KR KR1019870013062A patent/KR880006217A/en not_active Ceased
- 1987-11-20 DK DK609387A patent/DK168869B1/en not_active IP Right Cessation
- 1987-11-20 MY MYPI87003074A patent/MY103191A/en unknown
-
1991
- 1991-03-15 GR GR90401110T patent/GR3001611T3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT86166B (en) | 1990-11-20 |
| HUT46329A (en) | 1988-10-28 |
| FI875095A7 (en) | 1988-05-22 |
| ZA878656B (en) | 1988-08-31 |
| NZ222608A (en) | 1990-09-26 |
| EP0274346A1 (en) | 1988-07-13 |
| IL84494A (en) | 1992-08-18 |
| DK168869B1 (en) | 1994-06-27 |
| IE873147L (en) | 1988-05-21 |
| JPS63150290A (en) | 1988-06-22 |
| IE60148B1 (en) | 1994-06-01 |
| MY103191A (en) | 1993-05-29 |
| AU8145287A (en) | 1988-05-26 |
| ES2038693T3 (en) | 1993-08-01 |
| NO170283B (en) | 1992-06-22 |
| FI87653C (en) | 1993-02-10 |
| PH23959A (en) | 1990-01-23 |
| NO170283C (en) | 1992-09-30 |
| DE3768463D1 (en) | 1991-04-11 |
| CA1324383C (en) | 1993-11-16 |
| DK609387A (en) | 1988-05-22 |
| NO874855D0 (en) | 1987-11-20 |
| NO874855L (en) | 1988-05-24 |
| EP0274346B1 (en) | 1991-03-06 |
| ATE61371T1 (en) | 1991-03-15 |
| GR3001611T3 (en) | 1992-11-23 |
| AU605203B2 (en) | 1991-01-10 |
| KR880006217A (en) | 1988-07-22 |
| FI87653B (en) | 1992-10-30 |
| IL84494A0 (en) | 1988-04-29 |
| DD265900A5 (en) | 1989-03-15 |
| FI875095A0 (en) | 1987-11-18 |
| HU201087B (en) | 1990-09-28 |
| PT86166A (en) | 1987-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO173446C (en) | Analogous Procedures for the Preparation of New, Therapeutically Active, Substituted Alkandiphosphonic Acids | |
| ES539658A0 (en) | PROCEDURE FOR THE PREPARATION OF NEW XANTHINE DERIVATIVES AND THEIR ADDITIONAL SALTS WITH APPROPRIATE ACIDS | |
| DK114783D0 (en) | HIS UNKNOWN RELATIONS, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES | |
| EP0398720A3 (en) | Piperazine derivatives | |
| DK609387A (en) | HETEROARYLAMINOMETHANDIPHOSPHONIC ACIDS AND THEIR PREPARATION AND USE | |
| ATE144900T1 (en) | USE OF XANTHINE DERIVATIVES AGAINST STOMACH ULCER |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment | ||
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |